Azo-based hypoxic-activated 6-diazo-5-oxo-L-norleucine (DON) prodrug combined with vascular disrupting agent nanoparticles for tumor-selective glutamine metabolism blockade
- Resource Type
- Article
- Source
- In
Chemical Engineering Journal 1 February 2024 481 - Subject
- Language
- ISSN
- 1385-8947